GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,788,444 | +9.6% | 76,303 | +31.4% | 0.05% | +20.5% |
| Q2 2023 | $3,456,833 | -2.6% | 58,059 | -7.3% | 0.04% | -7.1% |
| Q1 2023 | $3,548,893 | -24.9% | 62,657 | -1.5% | 0.04% | -28.8% |
| Q4 2022 | $4,724,315 | +28.1% | 63,610 | +2.7% | 0.06% | +18.0% |
| Q3 2022 | $3,688,000 | -0.9% | 61,917 | -6.6% | 0.05% | +4.2% |
| Q2 2022 | $3,722,000 | -30.0% | 66,295 | -8.0% | 0.05% | -15.8% |
| Q1 2022 | $5,317,000 | +4.2% | 72,066 | +2.0% | 0.06% | +9.6% |
| Q4 2021 | $5,103,000 | -3.5% | 70,680 | +2.4% | 0.05% | 0.0% |
| Q3 2021 | $5,288,000 | -0.3% | 69,022 | +0.9% | 0.05% | 0.0% |
| Q2 2021 | $5,304,000 | +23.5% | 68,412 | -1.7% | 0.05% | +15.6% |
| Q1 2021 | $4,294,000 | -48.1% | 69,629 | -45.2% | 0.04% | -52.1% |
| Q4 2020 | $8,281,000 | +30.5% | 126,976 | -0.9% | 0.09% | +10.6% |
| Q3 2020 | $6,346,000 | -3.0% | 128,152 | -6.6% | 0.08% | -7.6% |
| Q2 2020 | $6,543,000 | +7.2% | 137,145 | -4.4% | 0.09% | -9.8% |
| Q1 2020 | $6,104,000 | -28.7% | 143,528 | -1.2% | 0.10% | -6.4% |
| Q4 2019 | $8,557,000 | +16.2% | 145,333 | +0.9% | 0.11% | +6.9% |
| Q3 2019 | $7,366,000 | +21.1% | 144,096 | +0.2% | 0.10% | +18.6% |
| Q2 2019 | $6,081,000 | -14.2% | 143,756 | +0.2% | 0.09% | -16.5% |
| Q1 2019 | $7,088,000 | +23.6% | 143,459 | +8.3% | 0.10% | +8.4% |
| Q4 2018 | $5,734,000 | -19.8% | 132,476 | +5.1% | 0.10% | -5.9% |
| Q3 2018 | $7,152,000 | +125.2% | 125,997 | +100.2% | 0.10% | +114.9% |
| Q2 2018 | $3,176,000 | +7.0% | 62,938 | +5.7% | 0.05% | +2.2% |
| Q1 2018 | $2,967,000 | +22.6% | 59,552 | +1.1% | 0.05% | +24.3% |
| Q4 2017 | $2,420,000 | +43.4% | 58,892 | +3.8% | 0.04% | +32.1% |
| Q3 2017 | $1,687,000 | -11.6% | 56,758 | -1.4% | 0.03% | -15.2% |
| Q2 2017 | $1,909,000 | +16.8% | 57,575 | +4.3% | 0.03% | +13.8% |
| Q1 2017 | $1,634,000 | +14.7% | 55,179 | -3.9% | 0.03% | +7.4% |
| Q4 2016 | $1,424,000 | +3211.6% | 57,408 | +3257.2% | 0.03% | +2600.0% |
| Q1 2015 | $43,000 | -25.9% | 1,710 | -29.8% | 0.00% | 0.0% |
| Q4 2014 | $58,000 | +41.5% | 2,435 | +16.8% | 0.00% | 0.0% |
| Q3 2014 | $41,000 | +7.9% | 2,085 | +30.3% | 0.00% | 0.0% |
| Q2 2014 | $38,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |